X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (205) 205
Book / eBook (14) 14
Patent (13) 13
Publication (13) 13
Newspaper Article (6) 6
Book Review (5) 5
Conference Proceeding (5) 5
Magazine Article (5) 5
Book Chapter (3) 3
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (88) 88
index medicus (80) 80
female (65) 65
pregnancy (51) 51
antiphospholipid syndrome (38) 38
immunology (35) 35
male (34) 34
adult (32) 32
rheumatology (28) 28
systemic lupus erythematosus (28) 28
thrombosis (27) 27
middle aged (26) 26
antiphospholipid antibodies (25) 25
systemic-lupus-erythematosus (22) 22
antiphospholipid syndrome - immunology (21) 21
autoimmunity (19) 19
management (19) 19
aged (16) 16
antibodies (16) 16
risk factors (16) 16
lupus (15) 15
allergy and immunology (14) 14
antiphospholipid syndrome - complications (14) 14
autoimmune diseases (14) 14
chemistry (14) 14
pregnancy complications - immunology (14) 14
pregnancy outcome (14) 14
young adult (14) 14
analysis (13) 13
antibodies, antiphospholipid - immunology (13) 13
metallurgy (13) 13
treatment outcome (13) 13
women (13) 13
animals (12) 12
autoantibodies (12) 12
lupus erythematosus, systemic - immunology (12) 12
prospective studies (12) 12
retrospective studies (12) 12
rheumatic diseases (12) 12
beta 2-glycoprotein i - immunology (11) 11
hydroxychloroquine (11) 11
lupus anticoagulant (11) 11
research (11) 11
abridged index medicus (10) 10
animal and vegetable oils, fats, fatty substances and waxes (10) 10
antiphospholipid syndrome - drug therapy (10) 10
arthritis (10) 10
candles (10) 10
classification criteria (10) 10
criteria (10) 10
detergent compositions (10) 10
detergents (10) 10
fatty acids therefrom (10) 10
recovery of glycerol (10) 10
resin soaps (10) 10
risk-factors (10) 10
soap or soap-making (10) 10
use of single substances as detergents (10) 10
adolescent (9) 9
care and treatment (9) 9
disease (9) 9
disease-activity (9) 9
health aspects (9) 9
medicine & public health (9) 9
pregnant women (9) 9
risk (9) 9
antibodies, antiphospholipid - blood (8) 8
antiphospholipid syndrome - diagnosis (8) 8
diagnosis (8) 8
follow-up studies (8) 8
medicine (8) 8
anticardiolipin antibodies (7) 7
anticoagulants (7) 7
anticoagulants - therapeutic use (7) 7
autoantibodies - immunology (7) 7
blood clot (7) 7
classification (7) 7
cohort studies (7) 7
complement (7) 7
immunoglobulins (7) 7
lupus erythematosus, systemic - drug therapy (7) 7
medicine, general & internal (7) 7
primary antiphospholipid syndrome (7) 7
research article (7) 7
aps (6) 6
autoimmune-diseases (6) 6
child (6) 6
follow-up (6) 6
hematology (6) 6
italy - epidemiology (6) 6
lupus erythematosus, systemic - diagnosis (6) 6
oncology (6) 6
patients (6) 6
pharmacology & pharmacy (6) 6
pregnancy complications (6) 6
prevalence (6) 6
prevention (6) 6
recommendations (6) 6
rheumatoid arthritis (6) 6
rheumatoid-arthritis (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Robarts - Storage (3) 3
Online Resources - Online (2) 2
UTL at Downsview - May be requested (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BMC Medicine, ISSN 1741-7015, 12/2017, Volume 15, Issue 1, pp. 1 - 3
Abstract New 2016 ACR/EULAR classification criteria for primary Sjogren’s syndrome (SS) have been developed and endorsed by the ACR. The newly proposed... 
ACR | Anti-La/SSB | EULAR | Sjogren’s syndrome | Anti-Ro/SSA | Classification criteria
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33585
Cervical cancer is the third most common cancer in women worldwide. Persistent infection with high-risk HPV types, principally HPV16 and 18 is the main risk... 
KAZAL MOTIFS | CYSTEINE-RICH PROTEIN | MMP-2 | MATRIX-METALLOPROTEINASE | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | REGULATOR RECK | MATRIX-METALLOPROTEINASE-9 | TISSUE INHIBITOR | CANCER | CARCINOMA | Human papillomavirus 16 - physiology | Keratinocytes - virology | Papillomavirus E7 Proteins - physiology | Humans | DNA Primers - genetics | Papillomavirus E7 Proteins - genetics | Tissue Inhibitor of Metalloproteinase-2 - metabolism | Matrix Metalloproteinase 9 - metabolism | Uterine Cervical Neoplasms - metabolism | Base Sequence | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Papillomavirus Infections - etiology | Oncogene Proteins, Viral - physiology | Cell Line | Human papillomavirus 16 - pathogenicity | Matrix Metalloproteinase 2 - metabolism | Down-Regulation | Matrix Metalloproteinase 14 - metabolism | Uterine Cervical Neoplasms - genetics | GPI-Linked Proteins - metabolism | Cervical Intraepithelial Neoplasia - virology | Papillomavirus Infections - genetics | Host-Pathogen Interactions | Cervical Intraepithelial Neoplasia - etiology | Keratinocytes - metabolism | Papillomavirus Infections - metabolism | Uterine Cervical Neoplasms - etiology | Uterine Cervical Neoplasms - virology | Cervical Intraepithelial Neoplasia - metabolism | Cervical Intraepithelial Neoplasia - genetics | Matrix Metalloproteinases - metabolism | Human papillomavirus 16 - genetics | GPI-Linked Proteins - genetics | Infection | Proteins | Development and progression | Health aspects | Papillomavirus infections | Health sciences | Regulators | Matrix metalloproteinases | Laboratories | Viruses | Infections | Malignancy | Metastasis | Tissue inhibitor of metalloproteinase 2 | Macrophages | Tissues | Carcinogenesis | Risk factors | Ovarian cancer | Metastases | Carcinogens | Toxicology | Human papillomavirus | Cell cycle | Fibroblasts | Extracellular matrix | Cervical carcinoma | Lesions | Pharmaceutical sciences | Medical research | Risk groups | Secretion | Tumor cells | Invasiveness | Health risks | Keratinocytes | Cultures | Gene expression | Cervix | Gelatinase B | Virology | Gelatinase A | Studies | Medical prognosis | Cervical cancer | Cancer
Journal Article
Journal Article
2007, Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies
Web Resource
2007, Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies
Web Resource
by Jampol, Lee M and Glassman, Adam R and Liu, Danni and Liu, Judy C and Aiello, Lloyd Paul and Aiello, Lloyd P and Bressler, Neil M and Bressler, Susan B and Duh, Elia J and Quaggin, Susan and Wells, Michael B and Wells, John A and Wykoff, Charles C and Browning, David and Antoszyk, Andrew N and Antoszyk, Andrew and Price, Randall L and Price, Angela K and Price, Paula A and Fredenberg, Sherry L and Herby, Jenna T and Fleming, Christina J and McClain, Ashley A and McClain, Ashley and McClain, Donna and Ennis, Sarah A and Gallagher, Kelly R and Karow, Angella S and Grupp, Autumn C and Puskas, Danielle and Watson, Brandun and Watson, Lynn and Bojaj, Swann J and Balasubramaniam, Uma M and Styles, Donna R and Kuopus, Jeff A and Kimrey, Kathryn and Clark, Mark D and Clark, Loraine M and Clark, W. Lloyd and Jackson, Lisa A and McOwen, Michael D and Dunlap, Matt and Held, Susannah J and Pieramici, Dante J and Nasir, Ma'an A and Castellarin, Alessandro A and Dhoot, Dilsher and Fishbein, Sarah and Giust, Jack and Giust, Matthew and Wan, Lisha and Hanna, Michelle S and Rabena, Melvin D and Smith, Veronica A and Smith, Jerry and Smith, Christopher M and Smith, Bradley T and Bone, Layne J and Avery, Kelly and Walker, Aimee and Walker, Joseph P and Walker, Cathy and Shook, Aimee H and Esau, Sara and Ruvalcaba, Nitce L and Johnson, Tametha and Johnson, Melissa L and Johnson, David L and Johnson, Marilyn A and Johnson, Britta and Johnson, Paula A and Payne, John F and Swinford, Tiffany R and Taylor, Mallie M and Taylor, Gena and Taylor, Teresa and Garrison, Cassandra L and Miller, Heather R and Miller, Pam S and Miller, Peggy D and Miller, David T and Miller, David G and Houlahan, Amber R and O'Neill, Charlotte A and Floyd, Geri L and Floyd, Ashley and Parker, Marianne and Parker, Crystal C and Sease, Courtney and Graham, Margie and Graham, Tara and Spencer, Robin and Ogbuewu, Tiffany N and Studebaker, Ashley and Huggins, Meagan L and Huggins, Tyler and Spivey, Robbin and Jones, Brian and Jones, Michael Cullen and ... and Diabet Retinopathy Clinical Res Ne and Diabetic Retinopathy Clinical Research Network
Ophthalmology, ISSN 0161-6420, 07/2018, Volume 125, Issue 7, pp. 1054 - 1063
To assess systemic vascular endothelial growth factor (VEGF)-A levels after treatment with intravitreous aflibercept, bevacizumab, or ranibizumab.... 
METAANALYSIS | PHARMACOKINETICS | BEVACIZUMAB | INJECTION | OPHTHALMOLOGY | RETINOPATHY | SERUM | RANIBIZUMAB | PREMATURITY | DEGENERATION
Journal Article